Thangaraj Karuppuchamy

Thangaraj Karuppuchamy

Auto-generated profile, based on publicly available information

Thangaraj Karuppuchamy

Division of Gastroenterology, Department of Medicine, University of California San Diego , La Jolla, CA 92093-0063

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
KFKosuke Fujimoto
Kosuke Fujimoto
TKThangaraj Karuppuchamy
Thangaraj Karuppuchamy
NTNaoki Takemura
Naoki Takemura
MSMasaki Shimohigoshi
Masaki Shimohigoshi
TMTomohisa Machida
Tomohisa Machida
SUSatoshi Uematsu
Satoshi Uematsu
CD103+ dendritic cells (DCs) are the major conventional DC population in the intestinal lamina propria (LP). Our previous report showed that a small number of cells in the LP could be classified into four subsets based on the difference in CD11c/CD11b expression patterns: CD11chiCD11blo DCs, CD11chiCD11bhi DCs, CD11cintCD11bint macrophages, and CD11cintCD11bhi eosinophils. The CD11chiCD11bhi DCs, which are CD103+, specifically express TLR5 and induce the differentiation of naive B cells into IgA+ plasma cells. These DCs also mediate the differentiation of Ag-specific Th17 and Th1 cells in response to flagellin. We found that small intestine CD103+ DCs of the LP (LPDCs) could be divided into a small subset of CD8α+ cells and a larger subset of CD8α− cells. Flow cytometry analysis revealed that CD103+CD8α+ and CD103+CD8α− LPDCs were equivalent to CD11chiCD11blo and CD11chiCD11bhi subsets, respectively. We analyzed a novel subset of CD8α+ LPDCs to elucidate their immunological function. CD103+CD8α+ LPDCs expressed TLR3, TLR7, and TLR9 and produced IL-6 and IL-12p40, but not TNF-α, IL-10, or IL-23, following TLR ligand stimulation. CD103+CD8α+ LPDCs did not express the gene encoding retinoic acid-converting enzyme Raldh2 and were not involved in T cell-independent IgA synthesis or Foxp3+ regulatory T cell induction. Furthermore, CD103+CD8α+ LPDCs induced Ag-specific IgG in serum, a Th1 response, and CTL activity in vivo. Accordingly, CD103+CD8α+ LPDCs exhibit a different function from CD103+CD8α− LPDCs in active immunity. This is the first analysis, to our knowledge, of CD8α+ DCs in the LP of the small intestine.

18 March 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
NTNaoki Takemura
Naoki Takemura
TKTakumi Kawasaki
Takumi Kawasaki
JKJun Kunisawa
Jun Kunisawa
SSShintaro Sato
Shintaro Sato
ALAayam Lamichhane
Aayam Lamichhane
SUSatoshi Uematsu
Satoshi Uematsu
High-dose ionizing radiation induces severe DNA damage in the epithelial stem cells in small intestinal crypts and causes gastrointestinal syndrome (GIS). Although the tumour suppressor p53 is a primary factor inducing death of crypt cells with DNA damage, its essential role in maintaining genome stability means inhibiting p53 to prevent GIS is not a viable strategy. Here we show that the innate immune receptor Toll-like receptor 3 (TLR3) is critical for the pathogenesis of GIS. Tlr3−/− mice show substantial resistance to GIS owing to significantly reduced radiation-induced crypt cell death. Despite showing reduced crypt cell death, p53-dependent crypt cell death is not impaired in Tlr3−/− mice. p53-dependent crypt cell death causes leakage of cellular RNA, which induces extensive cell death via TLR3. An inhibitor of TLR3–RNA binding ameliorates GIS by reducing crypt cell death. Thus, we propose blocking TLR3 activation as a novel approach to treat GIS.

1 January 2017 in Mucosal Immunology
Verified
Journal Article
Closed access
PDF file
TKT. Karuppuchamy
T. Karuppuchamy
EBE-H Behrens
E-H Behrens
PGP. González-Cabrera
P. González-Cabrera
GSG. Sarkisyan
G. Sarkisyan
LGL. Gima
L. Gima
JRJ. Rivera-Nieves
J. Rivera-Nieves

23 July 2012 in International Immunology
Verified
Journal Article
Open access
PDF file
TSTakuma Shibata
Takuma Shibata
NTNaoki Takemura
Naoki Takemura
YMYuji Motoi
Yuji Motoi
YGYoshiyuki Goto
Yoshiyuki Goto
TKThangaraj Karuppuchamy
Thangaraj Karuppuchamy
KMKensuke Miyake
Kensuke Miyake
Toll-like receptor 5 (TLR5), a sensor for bacterial flagellin, mounts innate and adaptive immune responses, and has been implicated in infectious diseases, colitis and metabolic syndromes. Although TLR5 is believed to belong to cell surface TLRs, cell surface expression has never been verified. Moreover, it has remained unclear which types of immune cells express TLR5 and contribute to flagellin-dependent responses. In this study we established an anti-mouse TLR5 monoclonal antibody and studied the cell surface expression of TLR5 on immune cells. The macrophage cell line J774 expressed endogenous TLR5 on the cell surface and produced IL-6 and G-CSF in response to flagellin. Cell surface expression of TLR5 and flagellin-induced responses were completely abolished by silencing a TLR-specific chaperone protein associated with TLR4 A (PRAT4A), demonstrating that TLR5 is another client of PRAT4A. In the in vivo immune cells, cell surface TLR5 was mainly found on neutrophils and CD11bhiLy6Chiclassical monocytes in the bone marrow, circulation, spleen and inflammatory lesions. Ly6Chiclassical monocytes, but not neutrophils, produced cytokines in response to flagellin. Splenic CD8−CD4+conventional dendritic cells and CD11chiCD11bhilamina propria DCs, also clearly expressed cell surface TLR5. Collectively, cell surface expression of TLR5 is dependent on PRAT4A and restricted to neutrophils, classical monocytes and specific DC subsets.

1 November 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KMKenta Maruyama
Kenta Maruyama
TKTakahiko Kawasaki
Takahiko Kawasaki
Masahide HamaguchiMasahide Hamaguchi
Masahide Hamaguchi
MHMotomu Hashimoto
Motomu Hashimoto
MFMoritoshi Furu
Moritoshi Furu
SAShizuo Akira
Shizuo Akira
Netrin 1 was initially identified as an axon guidance factor, and recent studies indicate that it inhibits chemokine-directed monocyte migration. Despite its importance as a neuroimmune guidance cue, the role of netrin 1 in osteoclasts is largely unknown. Here we detected high netrin 1 levels in the synovial fluid of rheumatoid arthritis patients. Netrin 1 is potently expressed in osteoblasts and synovial fibroblasts, and IL-17 robustly enhances netrin 1 expression in these cells. The binding of netrin 1 to its receptor UNC5b on osteoclasts resulted in activation of SHP1, which inhibited VAV3 phosphorylation and RAC1 activation. This significantly impaired the actin polymerization and fusion, but not the differentiation of osteoclast. Strikingly, netrin 1 treatment prevented bone erosion in an autoimmune arthritis model and age-related bone destruction. Therefore, the netrin 1-UNC5b axis is a novel therapeutic target for bone-destructive diseases.

17 February 2025 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PKPrabhdeep Kaur
Prabhdeep Kaur
TKThangaraj Karuppuchamy
Thangaraj Karuppuchamy
ACAmruth Chilukuri
Amruth Chilukuri
MKMargaret Kim
Margaret Kim
JUJosef Urrete
Josef Urrete
JRJesús Rivera-Nieves
Jesús Rivera-Nieves
Background: Sphingosine-1-phospate (S1P) receptor agonists (eg, ozanimod) desensitize migrating lymphocytes by irreversibly binding to S1P receptors (S1PR) and triggering their proteasomal degradation. Desensitized lymphocytes cannot sense S1P, therefore, halting lymphocyte recirculation. The S1P lyase (SPL) irreversibly degrades S1P and its inhibition disrupts the S1P gradient. We previously found that systemic SPL inhibitors induce central immunosuppression. Here, we examined whether SPL inhibition may attenuate colitis without systemic immunotoxicity. Methods: We first analyzed SPL expression and localization in mice using qRT-PCR and immunohistochemistry. SPL inhibitors 4-deoxypyridoxine hydrochloride (DOP) and 2-acetyl-4-(tetrahydroxybutyl) imidazole (THI) were used to inhibit SPL systemically, whereas a conditional intestinal epithelial cell (IEC)-specific SPL-deficient mouse was used to evaluate the effects of IEC-specific SPL inhibition on survival, disease activity, histological severity of dextran sulfate sodium-induced colitis, S1P levels, and intestinal permeability. Results: Sgpl1 mRNA transcripts and protein were ubiquitously expressed in gastrointestinal (GI) tract leukocytes and IEC. Systemic SPL inhibitors did not induce colitis by themselves but depleted CD4+ and CD8+ T cells from blood. However, contrary to its therapeutic effects on ileitis, systemic inhibition reduced survival, accelerated weight loss, worsened histopathological inflammation indices, and tissue damage. We then examined the effects of IEC-specific inhibition on peripheral cell counts and severity of colitis. We found that while it spared peripheral immunity, it similarly hastened colitis. Finally, we examined whether colitis acceleration was due to epithelial barrier compromise after disruption of the S1P gradient. We found that not only systemic but also IEC-specific SPL inhibition increased local S1P levels and led to IEC barrier compromise. Conclusion: Homeostatic intestinal S1P levels are critical for the regulation of IEC barrier function. Further studies using adaptive immunity-based inflammatory bowel diseases (IBD) models are required to assess the translational value of IEC-specific SPL inhibition as a therapeutic target for human IBD.